Long chain acyl CoA synthetase 1 and gelsolin are oppositely regulated in adipogenesis and lipogenesis

Biochemical and Biophysical Research Communications

Volumn 420, Issue 3, 2012, Pages 588-593

  Mukherjee, Rajib ^a   Yun, Jong Won ^a  

^a Daegu University   (South Korea)

Author keywords

3T3 L1; Gelsolin; Knockdown; Lipogenesis; Long chain acyl CoA synthetase 1; Obesity

Indexed keywords

ACYL COENZYME A SYNTHETASE 1; GELSOLIN; INTERLEUKIN 6; SMALL INTERFERING RNA; SYNTHETASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ARTICLE; CONTROLLED STUDY; ENZYME REGULATION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LIPOLYSIS; OBESITY; PRIORITY JOURNAL; PROTEOMICS; WHITE ADIPOSE TISSUE;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; COENZYME A LIGASES; GELSOLIN; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; INTERLEUKIN-6; LIPOGENESIS; MICE; OBESITY; RATS; RNA, SMALL INTERFERING; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 84859598896     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.03.038     Document Type: Article

References (40)

1. Rosen E.D., Spiegelman B.M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006, 444:847-853.
2. Waki H., Tontonoz P. Endocrine functions of adipose tissue. Annu. Rev. Pathol. 2007, 2:31-56.
3. Kopelman P.G. Obesity as a medical problem. Nature 2000, 404:635-643.
4. Green H., Meuth M. An established pre-adipose cell line and its differentiation in culture. Cell 1974, 3:127-133.
5. Joo J.I., Oh T.S., Kim D.H., Choi D.K., Wang X., Choi J.W., Yun J.W. Differential expression of adipose tissue proteins between obesity-susceptible and -resistant rats fed a high-fat diet. Proteomics 2011, 11:1429-1448.
6. Soupene E., Kuypers F.A. Mammalian long-chain acyl-CoA synthetases. Exp. Biol. Med. (Maywood) 2008, 233:507-521.
7. Li L.O., Mashek D.G., An J., Doughman S.D., Newgard C.B., Coleman R.A. Overexpression of rat long chain acyl-coa synthetase 1 alters fatty acid metabolism in rat primary hepatocytes. J. Biol. Chem. 2006, 281:37246-37255.
8. Mashek D.G., Li L.O., Coleman R.A. Rat long-chain acyl-CoA synthetase mRNA, protein, and activity vary in tissue distribution and in response to diet. J. Lipid Res. 2006, 47:2004-2010.
9. Schaffer J.E., Lodish H.F. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell 1994, 79:427-436.
10. Chiu H.C., Kovacs A., Ford D.A., Hsu F.F., Garcia R., Herrero P., Saffitz J.E., Schaffer J.E. A novel mouse model of lipotoxic cardiomyopathy. J. Clin. Invest. 2001, 107:813-822.
11. Kwiatkowski D.J. Functions of gelsolin: motility, signaling, apoptosis, cancer. Curr. Opin. Cell. Biol. 1999, 11:103-108.
12. DiNubile M.J. Plasma gelsolin as a biomarker of inflammation. Arthritis Res. Ther. 2008, 10:124.
13. Becker P.M., Kazi A.A., Wadgaonkar R., Pearse D.B., Kwiatkowski D., Garcia J.G. Pulmonary vascular permeability and ischemic injury in gelsolin-deficient mice. Am. J. Respir. Cell. Mol. Biol. 2003, 28:478-484.
14. Witke W., Sharpe A.H., Hartwig J.H., Azuma T., Stossel T.P., Kwiatkowski D.J. Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin. Cell 1995, 81:41-51.
15. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
16. Wang X., Choi J.W., Joo J.I., Kim D.H., Oh T.S., Choi D.K., Yun J.W. Differential expression of liver proteins between obesity-prone and obesity-resistant rats in response to a high-fat diet. Br. J. Nutr. 2011, 106:612-626.
17. Kim D.H., Choi J.W., Joo J.I., Wang X., Choi D.K., Oh T.S., Yun J.W. Changes in expression of skeletal muscle proteins between obesity-prone and obesity-resistant rats induced by a high-fat diet. J. Proteome Res. 2011, 10:1281-1292.
18. Choi J.W., Wang X., Joo J.I., Kim D.H., Oh T.S., Choi D.K., Yun J.W. Plasma proteome analysis in diet-induced obesity-prone and obesity-resistant rats. Proteomics 2010, 10:4386-4400.
19. Mashek D.G., Li L.O., Coleman R.A. Long-chain acyl-CoA synthetases and fatty acid channeling. Future Lipidol. 2007, 2:465-476.
20. Wang Y.L., Guo W., Zang Y., Yaney G.C., Vallega G., Getty-Kaushik L., Pilch P., Kandror K., Corkey B.E. Acyl coenzyme a synthetase regulation: putative role in long-chain acyl coenzyme a partitioning. Obes. Res. 2004, 12:1781-1788.
21. Mashek D.G., Bornfeldt K.E., Coleman R.A., Berger J., Bernlohr D.A., Black P., DiRusso C.C., Farber S.A., Guo W., Hashimoto N., Khodiyar V., Kuypers F.A., Maltais L.J., Nebert D.W., Renieri A., Schaffer J.E., Stahl A., Watkins P.A., Vasiliou V., Yamamoto T.T. Revised nomenclature for the mammalian long-chain acyl-CoA synthetase gene family. J. Lipid Res. 2004, 45:1958-1961.
22. Oikawa E., Iijima H., Suzuki T., Sasano H., Sato H., Kamataki A., Nagura H., Kang M.J., Fujino T., Suzuki H., Yamamoto T.T. A novel acyl-CoA synthetase, ACS5, expressed in intestinal epithelial cells and proliferating preadipocytes. J. Biochem. 1998, 124:679-685.
23. Martin G., Schoonjans K., Lefebvre A.M., Staels B., Auwerx J. Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators. J. Biol. Chem. 1997, 272:28210-28217.
24. Gregoire F.M., Smas C.M., Sul H.S. Understanding adipocyte differentiation. Physiol. Rev. 1998, 78:783-809.
25. Fajas L., Auboeuf D., Raspe E., Schoonjans K., Lefebvre A.M., Saladin R., Najib J., Laville M., Fruchart J.C., Deeb S., Vidal-Puig A., Flier J., Briggs M.R., Staels B., Vidal H., Auwerx J. The organization, promoter analysis, and expression of the human PPARgamma gene. J. Biol. Chem. 1997, 272:18779-18789.
26. Hardie D.G. Regulation of fatty acid and cholesterol metabolism by the AMP-activated protein kinase. Biochim. Biophys. Acta 1992, 1123:231-238.
27. Lobo S., Wiczer B.M., Bernlohr D.A. Functional analysis of long-chain acyl-CoA synthetase 1 in 3T3-L1 adipocytes. J. Biol. Chem. 2009, 284:18347-18356.
28. Koya R.C., Fujita H., Shimizu S., Ohtsu M., Takimoto M., Tsujimoto Y., Kuzumaki N. Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss and cytochrome c release. J. Biol. Chem. 2000, 275:15343-15349.
29. Sun H.Q., Yamamoto M., Mejillano M., Yin H.L. Gelsolin, a multifunctional actin regulatory protein. J. Biol. Chem. 1999, 274:33179-33182.
30. Spinardi L., Witke W. Gelsolin and diseases. Subcell. Biochem. 2007, 45:55-69.
31. Kratchmarova I., Kalume D.E., Blagoev B., Scherer P.E., Podtelejnikov A.V., Molina H., Bickel P.E., Andersen J.S., Fernandez M.M., Bunkenborg J., Roepstorff P., Kristiansen K., Lodish H.F., Mann M., Pandey A. A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol. Cell. Proteomics 2002, 1:213-222.
32. Kawaji A., Ohnaka Y., Osada S., Nishizuka M., Imagawa M. Gelsolin, an actin regulatory protein, is required for differentiation of mouse 3T3-L1 cells into adipocytes. Biol. Pharm. Bull. 2010, 33:773-779.
33. Nishimura K., Ting H.J., Harada Y., Tokizane T., Nonomura N., Kang H.Y., Chang H.C., Yeh S., Miyamoto H., Shin M., Aozasa K., Okuyama A., Chang C. Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator. Cancer Res. 2003, 63:4888-4894.
34. Hotamisligil G.S., Spiegelman B.M. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994, 43:1271-1278.
35. Lee Y.H., Pratley R.E. The evolving role of inflammation in obesity and the metabolic syndrome. Curr. Diab. Rep. 2005, 5:70-75.
36. Uysal K.T., Wiesbrock S.M., Marino M.W., Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997, 389:610-614.
37. Di Gregorio G.B., Hensley L., Lu T., Ranganathan G., Kern P.A. Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity. Am. J. Physiol. Endocrinol. Metab. 2004, 287:E182-187.
38. Green A., Dobias S.B., Walters D.J., Brasier A.R. Tumor necrosis factor increases the rate of lipolysis in primary cultures of adipocytes without altering levels of hormone-sensitive lipase. Endocrinology 1994, 134:2581-2588.
39. Feingold K.R., Doerrler W., Dinarello C.A., Fiers W., Grunfeld C. Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis. Endocrinology 1992, 130:10-16.
40. van Hall G., Steensberg A., Sacchetti M., Fischer C., Keller C., Schjerling P., Hiscock N., Moller K., Saltin B., Febbraio M.A., Pedersen B.K. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J. Clin. Endocrinol. Metab. 2003, 88:3005-3010.